Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction

Journal of Pineal Research

Volumn 53, Issue 3, 2012, Pages 319-323

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Arroyo Ucar, Eduardo ^a   Reiter, Russel J ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

acute myocardial infarction; coronary artery disease; human; left ventricular remodelling; melatonin

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MELATONIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE REMODELING; HEART VENTRICLE REMODELING; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PROSPECTIVE STUDY; SECONDARY PREVENTION;

AGED; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84866263440     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2012.01001.x     Document Type: Article

References (37)

1. Mann DL, Bogaev R, Buckberg GD,. Cardiac remodelling and myocardial recovery: lost in translation? Eur J Heart Fail 2010; 12: 789-796.
2. Sutton MG, Sharpe N,. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000; 101: 2981-2988. (Pubitemid 30415891)
3. Abbate A, Biondi-Zoccai GG, Baldi A,. Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol 2002; 193: 145-153.
4. Nian M, Lee P, Khaper N, et al., Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004; 94: 1543-1553. (Pubitemid 38856961)
5. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, et al., Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 2010; 49: 14-22.
6. Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ,. Clinical aspects of melatonin in the acute coronary syndrome. Curr Vasc Pharmacol 2009; 7: 367-373.
7. Tengattini S, Reiter RJ, Tan DX, et al., Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008; 44: 16-25. (Pubitemid 350231106)
8. Samimi-Fard S, Abreu-Gonzalez P, Dominguez-Rodriguez A, Jimenez-Sosa A,. A case-control study of melatonin receptor type 1A polymorphism and acute myocardial infarction in a Spanish population. J Pineal Res 2011; 51: 400-404.
9. Dayoub JC, Ortiz F, López LC, et al., Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide. J Pineal Res 2011; 51: 324-330.
10. Dubocovich ML, Markowska M,. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27: 101-110. (Pubitemid 41558442)
11. Boutin JA, Marcheteau E, Hennig P, et al., MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate. J Pineal Res 2008; 45: 524-531.
12. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, et al., Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis 2008; 199: 73-78. (Pubitemid 351842702)
13. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
14. Hardeland R, Tan DX, Reiter RJ,. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
15. Schaefer M, Hardeland R,. The melatonin metabolite N-acetyl-5- methoxykynuramine is a potent singlet oxygen scavenger. J Pineal Res 2009; 46: 49-52.
16. Simko F, Pechanova O, Pelouch V, et al., Continuous light and l-NAME-induced left ventricular remodelling: different protection with melatonin and captopril. J Hypertens 2010; 28 (Suppl 1): S13-S18.
17. Reiter RJ, Manchester LC, Fuentes-Broto L, et al., Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin. J Hypertens 2010; 28 (Suppl 1): S7-S12.
18. Ghosh G, De K, Maity S, et al., Melatonin protects against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart. J Pineal Res 2007; 42: 71-82. (Pubitemid 44924328)
19. Yeung HM, Hung MW, Fung ML,. Melatonin ameliorates calcium homeostasis in myocardial and ischemia-reperfusion injury in chronically hypoxic rats. J Pineal Res 2008; 45: 373-382.
20. Kan G, Visser CA, Lie KI, et al., Early two-dimensional echocardiographic measurement of left ventricular ejection fraction in acute myocardial infarction. Eur Heart J 1984; 5: 210-217. (Pubitemid 14137971)
21. Nagueh SF, Middleton KJ, Kopelen HA, et al., Doppler tissue imaging: a non-invasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-1533. (Pubitemid 27486472)
22. Savoye C, Equine O, Tricot O, et al., Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). Am J Cardiol 2006; 98: 1144-1149. (Pubitemid 44584097)
23. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, et al., Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2006; 97: 1162-1164.
24. Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P,. Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction. Am J Cardiol 2011; 108: 955-958.
25. Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P, et al., Neopterin predicts left ventricular remodeling in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Atherosclerosis 2010; 211: 574-578.
26. Hirayama A, Kusuoka H, Yamamoto H, et al., Usefulness of plasma brain natriuretic peptide concentration for predicting subsequent left ventricular remodeling after coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol 2006; 98: 453-457. (Pubitemid 44162870)
27. Wei L,. Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis. Exp Mol Pathol 2011; 90: 74-78.
28. Cunnane SC, Manku MS, Oka M, et al., Enhanced vascular reactivity to various vasoconstrictor agents following pinealectomy in the rat: role of melatonin. Can J Physiol Pharmacol 1980; 58: 287-293. (Pubitemid 10135051)
29. Zanoboni A, Zanoboni-Muciaccia W,. Experimental hypertension in pinealectomized rats. Life Sci 1967; 6: 2327-2331.
30. Reiter RJ, Tan DX, Manchester LC, et al., Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007; 52: 11-28.
31. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, et al., Light/dark patterns of soluble vascular cell adhesion molecule-1 in relation to melatonin in patients with ST-segment elevation myocardial infarction. J Pineal Res 2008; 44: 65-69. (Pubitemid 350231111)
32. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia M, et al., Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 2004; 26: 89-93. (Pubitemid 38410888)
33. Sia YT, Lapointe N, Parker TG, et al., Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat. Circulation 2002; 105: 2549-2555. (Pubitemid 34568979)
34. Nakamura R, Egashira K, Machida Y, et al., Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation. Circulation 2002; 106: 362-367. (Pubitemid 34778962)
35. Nelson FA, Farr LA, Ebadi M,. Salivary melatonin response to acute pain stimuli. J Pineal Res 2001; 30: 206-212. (Pubitemid 32336903)
36. Wilhelmsen M, Amirian I, Reiter RJ, et al., Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res 2011; 51: 270-277.
37. Caumo W, Levandovki R, Hidalgo MPL,. Preoperative anxiolityc effect of melatonin and clonidine on postoperative and morphine consumption in patients undergoing abdominal hysterectomy: a double-blind randomized, placebo-controlled study. J Pain 2009; 10: 100-108.